The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer’s Disease

2015/01/05 by Yanuar Alan Sulistio, Klaus Heese · 2 citations
Biochemistry, Genetics and Molecular Biology · Medicine · Neuroscience · #Alzheimer's disease #Alzheimer's disease research and treatments #Biochemistry #Biology #Cell biology #Chaperone (clinical) #Disease #Endoplasmic Reticulum Stress and Disease #Gene #Internal medicine #Medicine #Neurodegeneration #Neuroscience #Pathology #Proteasome #Ubiquitin #Ubiquitin and proteasome pathways

paper · doi:10.1007/s12035-014-9063-4

openalex publication_date 2015/01/05 · crossref created 2015/01/05 · crossref issued 2015/01/07 · crossref published 2015/01/07 · crossref published-online 2015/01/07 · crossref published-print 2016/03/01 · crossref deposited 2024/06/06 · openalex created_date 2025/10/10 · crossref indexed 2026/07/13 · openalex updated_date 2026/07/29

Citations

• Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?
• Gene encoding a new RING-B-box-Coiled-coil protein is mutated in mulibrey nanism
• Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
• Intrinsically unstructured proteins and their functions
• REVIEW: tau protein pathology in Alzheimer’s disease and related disorders
• Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
• Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
• Neuropathological stageing of Alzheimer-related changes
• Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
• Unique drug screening approach for prion diseases identifies tacrolimus and astemizole as antiprion agents

Cited by

• From Mitochondrial Function to Neuroprotection—an Emerging Role for Methylene Blue
• Proteasome [wikipedia]